scholarly article | Q13442814 |
P356 | DOI | 10.1002/GCC.10218 |
P698 | PubMed publication ID | 12800145 |
P50 | author | Daniel Birnbaum | Q64516222 |
Anne Letessier | Q115583307 | ||
Marie-Joëlle Mozziconacci | Q40291115 | ||
Jocelyne Jacquemier | Q42215390 | ||
José Adélaïde | Q42215698 | ||
Christophe Ginestier | Q51116930 | ||
Charles Theillet | Q55664894 | ||
Cornel Popovici | Q57331599 | ||
P2093 | author name string | Max Chaffanet | |
Marie-Joëlle Mozziconacci | |||
Béatrice Orsetti | |||
Paul A W Edwards | |||
Anne Murati | |||
Amber E Alsop | |||
Céline Basset | |||
Céline Courtay-Cahen | |||
Huai-En Huang | |||
P2860 | cites work | A role for common fragile site induction in amplification of human oncogenes | Q63869173 |
The Heregulin gene can be included in the 8p12 amplification unit in human breast cancer | Q71666526 | ||
Chromosome analysis of 97 primary breast carcinomas: identification of eight karyotypic subgroups | Q71688238 | ||
Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes | Q74623191 | ||
Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase | Q22009917 | ||
Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells | Q22254298 | ||
Carcinogenesis and translational controls: TACC1 is down-regulated in human cancers and associates with mRNA regulators | Q24303946 | ||
Ligands for ErbB-family receptors encoded by a neuregulin-like gene | Q24324186 | ||
Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases | Q24324224 | ||
Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4 | Q24336447 | ||
Identification of heregulin, a specific activator of p185erbB2 | Q24338146 | ||
A comprehensive genetic map of the human genome based on 5,264 microsatellites | Q27860812 | ||
Heregulin induces tyrosine phosphorylation of HER4/p180erbB4 | Q28589513 | ||
The ErbB signaling network: receptor heterodimerization in development and cancer | Q29617919 | ||
Role of neuregulins in glial cell development | Q33811048 | ||
Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer | Q34154327 | ||
Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma | Q34160782 | ||
Fragile and unstable chromosomes in cancer: causes and consequences | Q34264402 | ||
Neuregulin and ErbB receptor signaling pathways in the nervous system | Q34278032 | ||
Neuregulins and their receptors: a versatile signaling module in organogenesis and oncogenesis | Q34431223 | ||
Cytogenetic clues to breast carcinogenesis | Q34464929 | ||
Splicing regulation as a potential genetic modifier | Q34540777 | ||
The role of c-erbB-2/HER2/neu in breast cancer progression and metastasis | Q34639829 | ||
Compilation of published comparative genomic hybridization studies | Q34693285 | ||
Molecular alterations in sporadic breast cancer | Q34987420 | ||
DNA amplification at 11q13 in human cancer: from complexity to perplexity | Q35317211 | ||
Molecular cytogenetic analysis of 11 new breast cancer cell lines | Q36619975 | ||
Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT gene | Q38487400 | ||
Non-random chromosomal rearrangements in pancreatic cancer cell lines identified by spectral karyotyping | Q38494511 | ||
Characterization of recurrent homogeneously staining regions in 72 breast carcinomas | Q38502017 | ||
Cytogenetic analysis of three breast carcinoma cell lines using reverse chromosome painting | Q38503894 | ||
Molecular cytogenetic analysis of breast cancer cell lines | Q38785184 | ||
A neu acquaintance for erbB3 and erbB4: a role for receptor heterodimerization in growth signaling | Q40673334 | ||
Aberrations of chromosome 8 in 16 breast cancer cell lines by comparative genomic hybridization, fluorescence in situ hybridization, and spectral karyotyping | Q40807218 | ||
Chromosome translocations in breast cancer with breakpoints at 8p12. | Q40874525 | ||
Gamma-heregulin: a fusion gene of DOC-4 and neuregulin-1 derived from a chromosome translocation | Q40912133 | ||
gamma-heregulin is the product of a chromosomal translocation fusing the DOC4 and HGL/NRG1 genes in the MDA-MB-175 breast cancer cell line | Q40922469 | ||
Neuregulins in development | Q40943947 | ||
A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs | Q41009556 | ||
Differential characteristics of two new tumorigenic cell lines of human breast carcinoma origin | Q41025618 | ||
Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175. | Q41087264 | ||
Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons | Q41115353 | ||
Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells. | Q41701569 | ||
FRA3B and other common fragile sites: the weakest links | Q43922549 | ||
Constitutive fragile sites and cancer. | Q52849884 | ||
FGFRI andPLAT genes and DNA amplification at 8p 12 in breast and ovarian cancers | Q57287687 | ||
Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization | Q57981016 | ||
Integrated Map of the Chromosome 8p12–p21 Region, a Region Involved in Human Cancers and Werner Syndrome | Q58062339 | ||
A 3.1-Mb YAC contig within the Werner syndrome region, on the short arm of human chromosome 8 | Q58062375 | ||
Chromosome region 8p11-p21: Refined mapping and molecular alterations in breast cancer | Q61853727 | ||
P4510 | describes a project that uses | SK-BR-3 | Q7390592 |
MCF-7 | Q1881253 | ||
MDA-MB-468 | Q16880225 | ||
MDA-MB-231 | Q17577870 | ||
CFPAC-1 | Q28199352 | ||
HCC1937 | Q28872477 | ||
MT-3 | Q54906937 | ||
PANC-1 | Q54937550 | ||
PancTu-I | Q54937559 | ||
RWP-1 | Q54951495 | ||
SUIT-2 | Q54970817 | ||
SUM149PT | Q54970832 | ||
SUM159PT | Q54970841 | ||
SUM185PE | Q54970844 | ||
SUM44PE | Q54970850 | ||
SUM52PE | Q54970851 | ||
SW979 | Q54971228 | ||
T-47D | Q54971341 | ||
BT-20 | Q52392673 | ||
BrCa-MZ-01 | Q54798203 | ||
BrCa-MZ-02 | Q54798205 | ||
BT-474 | Q54798460 | ||
CAL-51 | Q54808406 | ||
CAMA-1 | Q54808432 | ||
Capan-2 | Q54808591 | ||
COLO 357 | Q54814099 | ||
GI-101A | Q54835803 | ||
HCC1187 | Q54881536 | ||
HCC1395 | Q54881565 | ||
HCC1500 | Q54881583 | ||
HCC1806 | Q54881605 | ||
HCC38 | Q54881712 | ||
MCF-10F | Q54904300 | ||
MDA-MB-134-VI | Q54904577 | ||
MDA-MB-157 | Q54904578 | ||
MDA-MB-175-VII | Q54904579 | ||
MDA-MB-361 | Q54904626 | ||
MDA-MB-415 | Q54904630 | ||
MDA-MB-453 | Q54904642 | ||
PaCa-3 | Q54905681 | ||
UACC-812 | Q54973863 | ||
VP229 | Q54993312 | ||
VP303 | Q54993324 | ||
ZR-75-1 | Q54996114 | ||
P433 | issue | 4 | |
P921 | main subject | pancreatic cancer | Q212961 |
cell line | Q21014462 | ||
P304 | page(s) | 333-345 | |
P577 | publication date | 2003-08-01 | |
P1433 | published in | Genes, Chromosomes and Cancer | Q5532697 |
P1476 | title | A recurrent chromosome translocation breakpoint in breast and pancreatic cancer cell lines targets the neuregulin/NRG1 gene | |
P478 | volume | 37 |